Showing posts with label Cardiology. Show all posts
Showing posts with label Cardiology. Show all posts

Sunday, 25 August 2013

Case Report 5 :: Chest X-ray in Heart Failure


Congestive Heart Failure Intro

 Results from any structural or functional abnormality that impairs the ability of the ventricle to eject blood (Systolic Heart Failure) or to fill with blood (Diastolic Heart Failure).



Chest X-ray in Heart Failure
  •  Cardiomegaly
  •  Cephalization of the pulmonary vessels
  •  Kerley B-lines
  •  Pleural effusions
Kerley B-lines
 Pulmonary Edema due to Heart Failure


Pulmonary vessel congestion
 Cardiomegaly



Wednesday, 24 July 2013

Biomarkers of Cardiac Ischemia

There have been progressive developments within basic and clinical research to identify candidate biomarkers of ischemia and to develop simple to use assays. Any such assay needs to have similar analytical (limit of detection, precision, reference intervals) and clinical performance (sensitivity, specificity, risk stratification and predictive value) compared to that of markers of necrosis, such as high sensitivity cardiac troponin assays. A number of candidate biomarkers have been identified. However very few make it from a research grade assay to a fully licenced automated assay for clinical use. The most promising biomarkers to date are reviewed below. Of these, Ischemia Modified Albumin has been the most successful biomarker and greater attention is given to this marker.


Malondialdehyde low density lipoprotein

Malondialdehyde low density lipoprotein (MDA-LDL) is a sensitive biomarker for ACS patients with unstable angina and AMI. MDA is a candidate compound which causes oxidative modification of LDL. MDA (propanedial, C3H4O2) is a reactive aldehyde produced by degradation of polyunsaturated lipids or released during prostanoid metabolism. This reactive oxygen species causes oxidative modification to LDL. MDA-LDL reacts with the charged amino group of B-100 protein lysyl residues. Plasma concentrations of MDA-LDL identify patients with coronary artery disease. Modified LDL may also instigate an immune response leading to autoantibody and LDL immune complex production. MDA-LDL not only serves as an oxidative stress marker but as a marker of plaque destabilisation.

Source  ::   http://www.intechopen.com/



Case Report 4 :: Demand Ischemia

Today we talked about a case of a young man who essentially presented with status epilepticus and was found to have some non-specific ECG changes, a CXR compatible with CHF though without evidence of CHF on clinical exam, and an elevated cardiac troponin.

The discussent, a cardiologist, facilitated a good discussion on the approach to a patient with seizures including considering that what was labelled "seizure" may, in some patients with underlying cardiac dysrthmias or ischemic/structural heart disease be a presentation of primary cardiac abnormalities.

In this patient, who subsequently turned out to have a normal baseline ECG and a normal 2D echo and who will go on to angiography, the suspicion is that this troponin increase was caused by severe myocardial demand during the status epilepticus. The combination of catecholamine surge, increased muscle tone leading to increased afterload, and tachycardia presumably led to sub-endocardial ischemia.

There are conflicting case reports about whether seizures themselves can lead to troponin increases with one small patient series saying no, and several single patient case reports saying yes. I think the take home message from this is that you can't write off significantly elevated troponins as being entirely due to the seizure.

We spent some time discussing stress-induced cardiomyopathy or apical ballooning syndrome. There are some case reports of status epilepticus causing this syndrome (in one of these cases the troponin was elevated to 10!).

Also, if you haven't done so already, I would suggest you review the blog on seizures/status epilepticus.



Thursday, 18 July 2013

What happens during a Heart Attack?

This video shows what happens to the body when someone has a heart attack. I had to watch it for my Health ED class and I thought I would share. Feel free to ask any questions & add me on FB!






Source Youtube



Monday, 1 July 2013

Tricuspid Regurgitation



Tricuspid regurgitation is a disorder involving backflow of blood from the right ventricle to the right atrium during contraction of the right ventricle. The most common cause of tricuspid regurgitation is not damage to the valve itself but enlargement of the right ventricle, which may be a complication of any disorder that causes right ventricular failure.

Symptoms

  1. Shortness of Breath
  2. Active pulsing in neck veins
  3. Fatigue during strenuos activity
  4. Cough, at night
  5. Heart Palpitations
  6. Pedal Edema
  7. Heart murmur
  8. Excessive Urination
  9. Angina or tightness
  10. Dizziness
Doppler Echo

Treatment

Management of Tricuspid Regurgitation is treating underlying causes.
Medical Therapy is done using Diuertics and drugs that reduce afterload.
If Surgery is indicated following surgeries are performed
  1. Valvuloplasty
  2. Valve Replacement